Clinical pathogenesis of macular holes in patients affected by retinitis pigmentosa.

BACKGROUND To define the main clinical mechanisms involved in the pathogenesis of macular holes (MH) in patients affected by Retinitis Pigmentosa (RP). METHODS 236 RP subjects were enrolled in this study and ophthalmologically examined according to a standard FIARP (Italian Federation of the RP Associations) protocol. The prevalence of posterior vitreous detachment (PVD) as well as all types of RP-related macular abnormalities--especially vitreoretinal interface alterations (VRIA), cystoid macular edema (CME), "bull's eye maculopathy" (BEM) and MH--was reported; statistical analyses and correlations were assessed by means of Student t test and Pearson chi2. RESULTS VRIA and CME were observed in 26.15% and 9.45% of the cases respectively and resulted significantly associated with MH, since they were constantly present in 22 of the 25 eyes affected by MH (88%) (chi2 = 50.4; p < 0.01). In particular, in 9 of these cases (40.9%) MH was correlated to both CME and VRIA, while in 11 (50%) and 2 (9.1%) eyes CME or VRIA were present separately. A normal biomicroscopic macular appearance, PVD and BEM were found in 26.81%, 6.6% and 21.54% of the cases respectively. CONCLUSIONS Further studies involving a larger number of patients are required to complete these preliminary results. However, the present investigation seem to confirm the data already reported in the literature, i.e. that pathogenesis of MH in RP is strictly correlated to the presence of VRIA, cellophane maculopathy and cystic foveal degeneration with CME.

[1]  M. Matsumura,et al.  [A macular hole in the eye of a young patient with retinitis pigmentosa]. , 2002, Nippon Ganka Gakkai zasshi.

[2]  E. Vingolo,et al.  Deflazacort treatment of cystoid macular edema in patients affected by Retinitis Pigmentosa: a pilot study. , 2002, European review for medical and pharmacological sciences.

[3]  D. Albert,et al.  Principles and practice of ophthalmology , 1999 .

[4]  P. Onori,et al.  Vitreal alterations in retinitis pigmentosa: biomicroscopic appearance and statistical evaluation. , 1996, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde.

[5]  T. Dryja,et al.  Retinitis pigmentosa and allied diseases. Implications of genetic heterogeneity. , 1995, Investigative ophthalmology & visual science.

[6]  E. Berson Retinitis pigmentosa. The Friedenwald Lecture. , 1993, Investigative ophthalmology & visual science.

[7]  G. Fishman,et al.  Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. , 1989, Archives of ophthalmology.

[8]  J. Dowling,et al.  Retinitis Pigmentosa: A Symposium on Terminology and Methods of Examination , 1983 .

[9]  R. Pruett,et al.  Retinitis pigmentosa: clinical observations and correlations. , 1983, Transactions of the American Ophthalmological Society.

[10]  G. Fishman,et al.  Foveal lesions seen in retinitis pigmentosa. , 1977, Archives of ophthalmology.

[11]  G. Fishman,et al.  Macular lesions associated with retinitis pigmentosa. , 1977, Archives of ophthalmology.